DBV Technologies (DBVT) Other Non-Current Liabilities (2015 - 2025)

DBV Technologies (DBVT) reported Other Non-Current Liabilities of $8.4 million for Q3 2025, up 8.52% year-over-year from $7.8 million in Q3 2024, and up 12.38% quarter-over-quarter from $7.5 million in Q2 2025.

DBV Technologies (DBVT) Other Non-Current Liabilities (2015 - 2025) Analysis & Trends

DBV Technologies (DBVT) has 11 years of Other Non-Current Liabilities data on file, last reported at $8.4 million in Q3 2025.

  • Other Non-Current Liabilities for Q3 2025 came in at $8.4 million, up 8.52% year-over-year; the trailing twelve-month figure through Sep 2025 was $8.4 million (up 8.52% YoY), and the FY2024 annual result was $8.3 million, down 6.78% from the prior year.
  • Other Non-Current Liabilities improved to $8.4 million in Q3 2025 per DBVT's latest filing, from $7.5 million in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $17.0 million in Q3 2021 and troughed at $979000.0 in Q3 2022.
  • A 5-year average of $6.2 million and a median of $5.2 million in 2024 frame the typical range for Other Non-Current Liabilities.
  • The sharpest annual moves came in 2021 and 2022: Other Non-Current Liabilities surged 352.0% in 2021, then slumped 94.22% in 2022.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $2.1 million in 2021, then surged by 120.54% to $4.7 million in 2022, then surged by 88.68% to $8.9 million in 2023, then decreased by 6.78% to $8.3 million in 2024, then rose by 1.45% to $8.4 million in 2025.
  • Business Quant data shows DBVT's Other Non-Current Liabilities at $8.4 million in Q3 2025, $7.5 million in Q2 2025, and $5.4 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 DBV Technologies 6.63 Bn 6.41 Bn -3.90 Mn

Historic Data

Download Data
DateValue
Sep 30, 2025 8.45 Mn
Jun 30, 2025 7.52 Mn
Mar 31, 2025 5.45 Mn
Dec 31, 2024 8.33 Mn
Sep 30, 2024 7.79 Mn
Mar 31, 2024 5.02 Mn
Dec 31, 2023 8.93 Mn
Sep 30, 2023 2.70 Mn
Jun 30, 2023 11.25 Mn
Mar 31, 2023 4.39 Mn
Dec 31, 2022 4.74 Mn
Sep 30, 2022 979,000.00
Jun 30, 2022 10.54 Mn
Mar 31, 2022 1.46 Mn
Dec 31, 2021 2.15 Mn
Sep 30, 2021 16.95 Mn
Jun 30, 2021 3.47 Mn
Mar 31, 2021 1.29 Mn
Dec 31, 2020 475,000.00
Dec 31, 2019 1.63 Mn